gogo
Amazon cover image
Image from Amazon.com

Biochips as pathways to drug discovery / edited by Andrew Carmen and Gary Hardiman.

Contributor(s): Material type: TextTextSeries: Drug discovery series ; 7Publication details: Boca Raton, Fla. : CRC ; London : Taylor & Francis [distributor], 2006.Description: 750 p. ; 24 cmISBN:
  • 9781574444506 (hbk.) :
  • 9781574444506 (hbk.) :
Subject(s): DDC classification:
  • 615.19 CAR
LOC classification:
  • R857.B5 B54 2006
Contents:
1.DNA biochips - past, present, and future: an overview. Gary Hardiman and Andrew Carmen -- 2.Three-dimensional hydroarrays: novel microarrays for genomic and proteomic studies.Roberto Fagnani, Pavel Tsinberg, and Tony Pircher -- 3.Biochips in malaria for antiparasitic discovery. Karine Le Roch and Elizabeth Winzeler -- 4.Regional variations in intestintal ATP-binding cassette transporter expression identified with a global error assessment model. David M. Mutch, Anton Petrov, J. Bruce German, Gary Williamson, and Matthew-Alan Roberts -- 5.Toxicogenomics in drug safety evaluation: bridging drug discovery and development. Alex Y, Nie, Michael K. McMillan, and Peter G. Lord -- 6.The next generation of automated microarray platforms for a multiplexed CYP2D6 assya. Phillip Kim et al ... -- 7.Evaluation of skeletal muscle and adipose tissue biopsy procedures for microarray-based gene-expression profiling. M. B. A. van Doorn et al ... -- 8.ChIP-on-Chip: analysis of genomewide protein binding and posttranslational modifications. Daniel Robyr -- 9.DNA microarrays as functional genomics tools for cancer drug discover. Arindam Bhattacharjee -- 10.High-throughput microarray analysis. Sejal Sheth -- 11.Laboratory automation: strategies for high-volume industrial microarray programs. Anton Bittner and Andrew A. Carmen -- 12.Association studies: practical and theoretical considerations for drug discovery, evaluation, and beyond. Richard M. Kliman ... et al -- 13.Approaches for microarray data validation. Sergey E. Ilyin -- 14.Microarray enterprise information management: what is it and why is it important? -- 15.Quality control of microarray data. Huinian Xiao et al ... 16.Micro array data normalization and transformation. Huinian Xiao et al ... -- 17.Amplification strategies and DNA biochips. Barbara Ruggeri et al ... --18.Ribo-SPIA, a rapid isothermal RNA amplification method for gene expression analysis. Alan Dafforn et al ... -- 19.Genomics, transcriptomics, and proteomics: novel detection technologies and drug discovery. Phillip Stafford -- 20.Intellectual property issues for DNA chips and microarrays. Vicki G. Norton -- 21.Biochips: market drivers and commercial prospets. Jing Xu -- 22.A pharmaceutical perspective for microarrays and biochips: current-market overview and future trends. Lisa Milne.
Summary: With perspectives that look ahead to the future of this area, 'Biochips as Pathways to drug Discovery' provides an overview of the current state of biochip technology, examining the effects of biochips on biomedical research and specifically the pharmaceutical industry.
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Long Loan TUS: Midlands, Main Library Athlone General Lending 615.19 CAR (Browse shelf(Opens below)) 1 Available 204635

Includes bibliographical references.

1.DNA biochips - past, present, and future: an overview. Gary Hardiman and Andrew Carmen -- 2.Three-dimensional hydroarrays: novel microarrays for genomic and proteomic studies.Roberto Fagnani, Pavel Tsinberg, and Tony Pircher -- 3.Biochips in malaria for antiparasitic discovery. Karine Le Roch and Elizabeth Winzeler -- 4.Regional variations in intestintal ATP-binding cassette transporter expression identified with a global error assessment model. David M. Mutch, Anton Petrov, J. Bruce German, Gary Williamson, and Matthew-Alan Roberts -- 5.Toxicogenomics in drug safety evaluation: bridging drug discovery and development. Alex Y, Nie, Michael K. McMillan, and Peter G. Lord -- 6.The next generation of automated microarray platforms for a multiplexed CYP2D6 assya. Phillip Kim et al ... -- 7.Evaluation of skeletal muscle and adipose tissue biopsy procedures for microarray-based gene-expression profiling. M. B. A. van Doorn et al ... -- 8.ChIP-on-Chip: analysis of genomewide protein binding and posttranslational modifications. Daniel Robyr -- 9.DNA microarrays as functional genomics tools for cancer drug discover. Arindam Bhattacharjee -- 10.High-throughput microarray analysis. Sejal Sheth -- 11.Laboratory automation: strategies for high-volume industrial microarray programs. Anton Bittner and Andrew A. Carmen -- 12.Association studies: practical and theoretical considerations for drug discovery, evaluation, and beyond. Richard M. Kliman ... et al -- 13.Approaches for microarray data validation. Sergey E. Ilyin -- 14.Microarray enterprise information management: what is it and why is it important? -- 15.Quality control of microarray data. Huinian Xiao et al ... 16.Micro array data normalization and transformation. Huinian Xiao et al ... -- 17.Amplification strategies and DNA biochips. Barbara Ruggeri et al ... --18.Ribo-SPIA, a rapid isothermal RNA amplification method for gene expression analysis. Alan Dafforn et al ... -- 19.Genomics, transcriptomics, and proteomics: novel detection technologies and drug discovery. Phillip Stafford -- 20.Intellectual property issues for DNA chips and microarrays. Vicki G. Norton -- 21.Biochips: market drivers and commercial prospets. Jing Xu -- 22.A pharmaceutical perspective for microarrays and biochips: current-market overview and future trends. Lisa Milne.

With perspectives that look ahead to the future of this area, 'Biochips as Pathways to drug Discovery' provides an overview of the current state of biochip technology, examining the effects of biochips on biomedical research and specifically the pharmaceutical industry.

Powered by Koha